Ardelyx’s ambition to revolutionise kidney treatment
pharmaphorum
DECEMBER 17, 2020
As the co-founder of the biopharma company, Raab has been focusing on advancing patient care for kidney disease since 2009. We must remember with kidney failure; these are patients who can also be hypertensive or diabetic. Patients who undergo dialysis are some of the most fragile.
Let's personalize your content